SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001178913-22-002049
Filing Date
2022-05-17
Accepted
2022-05-17 09:49:30
Documents
1
Period of Report
2022-03-31
Effectiveness Date
2022-05-17

Document Format Files

Seq Description Document Type Size
1 NT 10-Q zk2227854.htm NT 10-Q 28661
  Complete submission text file 0001178913-22-002049.txt   29988
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 22932579
SIC: 2890 Miscellaneous Chemical Products